Medications for Urinary Bladder Overactive

36 results

  • Darifenacin (darifenacin hydrobromide)

    (darifenacin hydrobromide)
    Alcon Laboratories Inc
    Usage: Darifenacin extended-release tablets are indicated for treating overactive bladder, specifically targeting symptoms such as urge urinary incontinence, urgency, and frequency.

  • Darifenacin (darifenacin hydrobromide)

    (Darifenacin Hydrobromide)
    POLYGEN PHARMACEUTICALS INC.
    Usage: Darifenacin extended-release tablets are indicated for the treatment of overactive bladder, specifically for managing symptoms of urge urinary incontinence, urgency, and frequency.

  • Darifenacin (darifenacin)

    (DARIFENACIN)
    Alembic Pharmaceuticals Inc.
    Usage: Darifenacin is a muscarinic antagonist indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency.

  • Enablex (darifenacin)

    (darifenacin)
    Physicians Total Care, Inc.
    Usage: ENABLEX® (darifenacin) extended-release tablets are indicated for treating overactive bladder, specifically addressing symptoms of urge urinary incontinence, urgency, and frequency.

  • Fesoterodine fumarate (fesoterodine fumarate)

    (FESOTERODINE FUMARATE)
    NorthStar RxLLC
    Usage: Fesoterodine fumarate extended-release tablets are indicated for treating overactive bladder (OAB) in adults and neurogenic detrusor overactivity (NDO) in pediatric patients aged 6 and older with a body weight over 25 kg.

  • Fesoterodine fumarate (fesoterodine fumarate)

    (Fesoterodine Fumarate)
    Ascend Laboratories, LLC
    Usage: Fesoterodine fumarate extended-release tablets are indicated for treating overactive bladder (OAB) in adults, specifically for symptoms of urge urinary incontinence, urgency, and frequency. Pediatric use information exists but is not included due to marketing exclusivity rights.

  • Fesoterodine fumarate (fesoterodine fumarate)

    (fesoterodine fumarate)
    Zydus Pharmaceuticals USA Inc.
    Usage: Fesoterodine fumarate extended-release tablets are indicated for treating adult overactive bladder (OAB) symptoms, such as urge urinary incontinence, urgency, and frequency. Additionally, they are used for neurogenic detrusor overactivity (NDO) in pediatric patients aged 6 and older, weighing over 25 kg.

  • Mirabegron (mirabegron)

    (Mirabegron)
    REMEDYREPACK INC.
    Usage: Mirabegron extended-release tablets are indicated for treating overactive bladder (OAB) in adults with urge urinary incontinence and frequency, as well as neurogenic detrusor overactivity (NDO) in pediatric patients aged 3 years and older who weigh at least 35 kg.

  • Oxybutynin chloride (oxybutynin chloride)

    (OXYBUTYNIN CHLORIDE)
    DIRECT RX
    Usage: Oxybutynin chloride extended-release tablets are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency. They are also approved for pediatric patients aged 6 years and older with detrusor overactivity linked to neurological conditions, such as spina bifida.

  • Oxybutynin chloride (oxybutynin chloride)

    (Oxybutynin Chloride)
    A-S Medication Solutions
    Usage: Oxybutynin chloride tablets are indicated for relieving bladder instability symptoms in patients with uninhibited neurogenic or reflex neurogenic bladder, including urgency, frequency, urinary leakage, urge incontinence, and dysuria.